Interactions industry
ADDN has interactions and collaborations with many industrial partners.
A few examples of IWT- or FP7-funded projects with industrial partners are indicated below:
GSK-DDW
OpenMedChem: Medicinal Chemistry Open Innovation Doctorates -Tuberculosis
Funding: Initial Training Network (MCA, FP7)
From: 01/10/2012 to 30/09/2016
Participant: Lab. of Medicinal Chemistry (UAMC)
J&J
- Project:
Benzodiazepine analogues for antifungal research- Participants: Lab. of Microbiology, Parasitology and Hygiene (LMPH), Lab. of Medicinal Chemistry (UAMC)
- Participants: Lab. of Microbiology, Parasitology and Hygiene (LMPH), Lab. of Medicinal Chemistry (UAMC)
- Project:
Immuno-PET: Immuno-positron emission tomography (PET) imaging as a potential biomarker for diagnosis and treatment in Alzheimer's disease.
This is a collaborative project with MICA & Laboratory for Translational Neuroscience.- Funding: IWT O&O (IWT Activity Report 2012)
- Participant: Laboratory of Medicinal Chemistry (UAMC)
Dafra Pharma
Project:
Extensive pharmacological study of the new anti-leishmania candidate drug oleylphosphocholine (OIPC) and exploration of other therapeutic applications to maximize the valorization value.
Funding:
- IWT SME (IWT Activity Report 2011)
Participant: Lab. of Microbiology, Parasitology and Hygiene (LMPH)